Stock: The Ensign Group (NASDAQ:ENSG) Misses Q4 CY2025 Sales Expectations

[Para 1: The Lead] The Ensign Group (NASDAQ:ENSG) reported Q4 CY2025 sales of $1.36 billion, 20.2% higher year-over-year but below market expectations. The company's GAAP earnings per share of $1.61 fell short of analysts' consensus by 3.4%. Despite missing on sales, The Ensign Group's full-year revenue guidance of $5.81 billion was 1.7% above estimates. [Para 2-3: Supporting details & Context] The Ensign Group, a healthcare services provider, saw its annualized revenue growth surge 18.2% over the last two years, outpacing its five-year trend of 16.8%. This acceleration is attributed to price increases rather than unit sales growth. Operating margin stood at 9.1% in Q4, stable from the prior year but down 1.7 percentage points over five years. EPS of $1.61 exceeded full-year guidance but missed Wall Street's estimates. Analysts forecast 17.5% growth in full-year EPS to $5.84 over the next 12 months, despite Q4's underperformance. The stock closed flat at $173.19 post-reporting.